secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2024-07-31T23:59:59+00:00
Accession:  0001174947-24-000936
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q2 adj EPS $0.98 beats; cuts FY revenue & EPS guidance on supply chain delays
--------------------------------------------------------------------------------

- Revenue $332.1M (+4.5% reported, +5.2% constant currency); GAAP EPS $0.96 vs $0.43; adj EPS $0.98 vs $0.83 (+18.1%).
- Full-year revenue guidance lowered to $1.305-1.315B from $1.330-1.355B; adj EPS guidance cut to $3.95-4.02 from $4.25-4.35.
- CEO cites unresolved supply chain challenges delaying commercial reacceleration, impacting second half outlook.
- Orthopedic Surgery sales -0.9% YoY; General Surgery +8.9%; Domestic +6.1%, International +2.6% reported.
- Adjusted EBITDA $64.6M (19.4% margin) vs $57.6M (18.1%) in Q2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000117494724000936/0001174947-24-000936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000117494724000936/form8k-32663_cnmd.htm
  HTML page:      https://secwatch.observer/filing/0001174947-24-000936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer